At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 239 enrolled
Drug / intervention
ACP-044 Dose A +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ACP-044 for Acute Postoperative Pain Following Orthopedic Surgery (Bunionectomy)
In Brief
A Phase 2 clinical trial evaluating ACP-044 Dose A, ACP-044 Dose B, and 1 other intervention for Acute Postoperative Pain and Bunionectomy. Completed, enrolled 239 participants across 4 sites.
Detailed Summary
To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Postoperative Pain, Bunionectomy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20222023202420252026
Enrollment StartMar 2021
First PostedApr 2021
Primary CompletionFeb 2022
Study CompletionMar 2022
TodayJul 2026
First PostedApr 22, 2021
Enrollment StartMar 29, 2021
Primary CompletionFeb 11, 2022
Study CompletionMar 14, 2022
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 5.2 years ago
Interventions
ACP-044 Dose Adrug
Oral dose of ACP-044 Dose A
ACP-044 Dose Bdrug
Oral dose of ACP-044 Dose B
Placebodrug
Oral dose of placebo